Drug search by name

Steglatro and Ketoacidosis

Result of checking the interaction of drug Steglatro and disease Ketoacidosis for safety when used together.

Check result:

Steglatro <> Ketoacidosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Ketoacidosis has been reported with the use of sodium glucose co-transporter-2 (SGLT2) inhibitors, such as ertugliflozin. Before initiating therapy with ertugliflozin, it is recommended to consider factors in the patient history that may predispose to ketoacidosis, including pancreatic insulin deficiency from any cause, caloric restriction, and alcohol abuse. Monitor for ketoacidosis and temporarily discontinue treatment in clinical situations known to predispose to ketoacidosis (e.g., prolonged fasting due to acute illness or surgery). Care should be exercised when using this agent in patients at risk of ketoacidosis.

Steglatro

Generic Name: ertugliflozin

Brand Name: Steglatro

Synonyms: n.a.

What is Steglatro?